Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.


  • Surgical trainees retain information, master skills better when honed beyond proficiency

  • Approach or buzz off: Brain cells in fruit fly hold secret to individual odor preferences

  • Warning labels should be introduced to prevent digital addiction, research suggests

  • Study sheds light on protecting transgender individuals from suicide

  • People with higher 'intellectual arrogance' get better grades

  • Immune gene prevents Parkinson's disease, dementia

  • Dying at home leads to more peace, less grief, but requires wider support

  • Math story time at home bolsters achievement in school

  • Seeing in a new light

  • Smoking, heavy alcohol use are associated with epigenetic signs of aging